NCT00032825View on ClinicalTrials.gov

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

674

Participants

Timeline

Start Date

March 19, 2002

Study Completion Date

June 13, 2011

Conditions
Prostatic Neoplasms
Interventions
DRUG

Ketaconazole

DRUG

Docetaxel

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00032825 - Ketoconazole Plus Docetaxel to Treat Prostate Cancer | Biotech Hunter | Biotech Hunter